U.S. markets closed
  • S&P Futures

    4,523.75
    +15.25 (+0.34%)
     
  • Dow Futures

    34,111.00
    +109.00 (+0.32%)
     
  • Nasdaq Futures

    15,936.50
    +66.75 (+0.42%)
     
  • Russell 2000 Futures

    2,154.50
    +8.20 (+0.38%)
     
  • Crude Oil

    65.70
    +0.13 (+0.20%)
     
  • Gold

    1,781.80
    -2.50 (-0.14%)
     
  • Silver

    22.41
    +0.07 (+0.32%)
     
  • EUR/USD

    1.1328
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    1.4340
    -0.0090 (-0.62%)
     
  • Vix

    31.12
    +3.93 (+14.45%)
     
  • GBP/USD

    1.3288
    +0.0011 (+0.08%)
     
  • USD/JPY

    113.0670
    +0.2870 (+0.25%)
     
  • BTC-USD

    57,183.54
    +144.99 (+0.25%)
     
  • CMC Crypto 200

    1,455.04
    -14.04 (-0.96%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,768.74
    -166.88 (-0.60%)
     

In Q3 earnings, Boston Scientific acknowledges Covid-19 headwinds

·3 min read
In Q3 earnings, Boston Scientific acknowledges Covid-19 headwinds
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In the company's third-quarter earnings call on Wednesday morning, Boston Scientific Corp. CEO Michael Mahoney acknowledged the business effects of the Delta surge of Covid-19, but said he was optimistic that they were temporary setbacks.